PFE250516C17000
- 5.45
- 0.000.00%
Pfizer Newsroom
Express News | Pfizer Dissolves Share Stake in Akero Therapeutics- SEC Filing
Pfizer Options Spot-On: On May 13th, 100.17K Contracts Were Traded, With 3.43 Million Open Interest
Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. -- Barrons.com
The USA will announce the selection list for the third round of drug price negotiations in February next year.
The USA Medical Insurance and Medical Assistance Services Center (CMS) plans to list up to 15 drugs selected for the third round of price negotiations before February 1, 2026, and is seeking public opinion.
Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock
Daily short sale tracking: Intel's short volume increased by 10 million, with a short sale ratio of 18%
Express News | Pfizer Netherlands International Finance B.v.: Files for Four-Part Euro-Denominated Notes Offering; Size Not Disclosed – SEC Filing
Pfizer (PFE.US) has launched the PD-L1 ADC clinical trial for the first time in the domestic market.
Pfizer (PFE.US) PD-L1 ADC has launched clinical trials domestically for the first time.
"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".
① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.
Drugmakers Spared Worst-Case Drug Pricing Scenario for Now
Pfizer Options Spot-On: On May 12th, 219.97K Contracts Were Traded, With 3.53 Million Open Interest
Equity Markets Higher After US-China Suspend Tariffs
Nvidia, Amazon, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont: Biggest Stock Movers
These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More -- Barrons.com
Sector Update: Health Care Stocks Climb Monday Afternoon
Pfizer on Track for Largest Percent Increase Since December 2024 -- Data Talk
Sector Update: Health Care
Eli Lilly, Pfizer, Merck Shares Rise as Trump Restructures Drug Pricing, Pushing CVS, Cigna Lower
The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.
① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.
Top Midday Stories: Shares Rise on US-China 90-Day Trade Ceasefire; Trump Signs Order Targeting High Drug Prices